Business Wire (May 10, 2013)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (May 8, 2013)
-
Business Wire (Apr 25, 2013)
-
Business Wire (Mar 12, 2013)
-
Business Wire (Jan 4, 2013)
-
-
Business Wire (Nov 26, 2012)
-
Business Wire (Nov 20, 2012)
-
Business Wire (Nov 7, 2012)
-
Business Wire (Oct 26, 2012)
-
3 Healthcare Stocks With Minimal Debt, Predicted For GrowthZetaKap • Thu, Oct 25, 2012 -
-
Business Wire (Sep 12, 2012)
-
-
5 Low-Debt Healthcare Stocks Positioned For GrowthZetaKap • Thu, Aug 23, 2012
-
Business Wire (Aug 15, 2012)
To learn more about Seeking Alpha Pro, click here.
-
-
3 Healthcare Stocks With Minimal Debt, Predicted For GrowthZetaKap • Thu, Oct 25, 2012
-
-
-
5 Low-Debt Healthcare Stocks Positioned For GrowthZetaKap • Thu, Aug 23, 2012
-
-
-
Pharmaceutical And Biotechnology Insider Buys Last WeekGutone • Mon, Jul 2, 2012 -
-
-
-
-
10 Rallying Small-Caps Bought Up By InsidersKapitall • Fri, Sep 16, 2011
-
-
-
Mostly IPO Treats This HalloweenIPO Candy • Fri, Nov 5, 2010
-
A Look at the IPO PipelineIPO Candy • Thu, Jul 1, 2010
-
Market Turmoil Creates Slow Week for Biotech DealsThe Burrill Report • Sun, Jun 6, 2010 -
3 IPOs Planned for This WeekRenaissance Capital IPO Research • Tue, May 25, 2010
-
Business Wire (May 10, 2013)
-
Business Wire (May 8, 2013)
-
Business Wire (Apr 25, 2013)
-
Business Wire (Mar 12, 2013)
-
Business Wire (Jan 4, 2013)
-
Business Wire (Nov 26, 2012)
-
Business Wire (Nov 20, 2012)
-
Business Wire (Nov 7, 2012)
-
Business Wire (Oct 26, 2012)
-
Business Wire (Sep 12, 2012)
-
Business Wire (Aug 15, 2012)
-
Business Wire (Aug 7, 2012)
-
Business Wire (Aug 2, 2012)
-
Business Wire (Jun 20, 2012)
-
Business Wire (Jun 19, 2012)
-
Business Wire (Jun 14, 2012)
-
at MarketWatch.com (Jun 12, 2012)
GNMK vs. ETF Alternatives
Company Description
"We are a molecular diagnostics company, or a company which detects and measures DNA and RNA targets to diagnose disease and to optimize the treatment of patients, focused on developing and commercializing our eSensor detection technology. Our proprietary electrochemical technology enables fast,... More
